2009
DOI: 10.3109/08880010903271689
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral Arterial Tonometry in Assessing Endothelial Dysfunction in Pediatric Sickle Cell Disease

Abstract: Blunted RHI was seen in the majority of children with SCD, especially with increased symptomatology (1.53 and 1.71; p value .032). RHI was not normal in children on chronic transfusion or hydroxyurea. RHI correlated with reticulocyte fraction (Spearman r = -.47, p = .037). PAT merits further exploration as a measure of EDF in SCD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 14 publications
1
9
0
Order By: Relevance
“…To assess the potential import of associations between vascular measures and functional capacity reported, it is relevant to understand how vascular measures in this Fontan cohort compared with those of adolescents and young adults without Fontan circulation or congenital heart disease who underwent evaluation of vascular health. Interestingly, percentage of FMD was higher in this Fontan cohort (10.2±5.5%) than in many other disease states, including familial hypercholesterolemia (1.2±0.4%), hypertension (4.5±4.0%), and obesity (6.6±2.3%), whereas PAT‐RHI (1.2 [range 0.2–4.8]) and Framingham Heart Study modification of RHI (0.17±0.44) were lower compared with participants with type 2 diabetes mellitus (T2DM; 1.6±0.5), obesity (1.5±0.4), and sickle cell disease (1.6) . It is reasonable to infer from these comparisons that endothelial function might be better preserved in conduit arteries than in the more distal peripheral arteries of Fontan patients.…”
Section: Discussionmentioning
confidence: 57%
See 1 more Smart Citation
“…To assess the potential import of associations between vascular measures and functional capacity reported, it is relevant to understand how vascular measures in this Fontan cohort compared with those of adolescents and young adults without Fontan circulation or congenital heart disease who underwent evaluation of vascular health. Interestingly, percentage of FMD was higher in this Fontan cohort (10.2±5.5%) than in many other disease states, including familial hypercholesterolemia (1.2±0.4%), hypertension (4.5±4.0%), and obesity (6.6±2.3%), whereas PAT‐RHI (1.2 [range 0.2–4.8]) and Framingham Heart Study modification of RHI (0.17±0.44) were lower compared with participants with type 2 diabetes mellitus (T2DM; 1.6±0.5), obesity (1.5±0.4), and sickle cell disease (1.6) . It is reasonable to infer from these comparisons that endothelial function might be better preserved in conduit arteries than in the more distal peripheral arteries of Fontan patients.…”
Section: Discussionmentioning
confidence: 57%
“…Interestingly, percentage of FMD was higher in this Fontan cohort (10.2AE5.5%) than in many other disease states, including familial hypercholesterolemia (1.2AE0.4%), hypertension (4.5AE4.0%), and obesity (6.6AE2.3%), whereas PAT-RHI (1. disease (1.6). [28][29][30][31][32][33] It is reasonable to infer from these comparisons that endothelial function might be better preserved in conduit arteries than in the more distal peripheral arteries of Fontan patients. Laser flow Doppler was low in Fontan patients (1539 [range 1119-2213]) compared with both adolescent and young adult controls (2539AE1255) and those with T2DM (1870AE945).…”
Section: Discussionmentioning
confidence: 99%
“…The correlation between RHI and the age of subjects was reported as not statistically significant (Hamburg et al 2008). Endothelial function by RH-PAT with EndoPAT has also been studied in the pediatric population (Sivamurthy et al 2009).…”
Section: Introductionmentioning
confidence: 99%
“…A reduction of flow-mediated dilation or RHI has been reported when hemoglobin is released into plasma, such as in sickle cell disease, 10 malaria, 11 or during hemodialysis 12 . A complementary approach to assess the fate of nitric oxide is by nitric oxide metabolite profiling in blood.…”
Section: Introductionmentioning
confidence: 99%